Pharmacological basis for antihypertensive effects of intravenous labetalol
about
sameAs
Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effectsControversial therapeutics: the β-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma.Comparison of labetalol and propranolol in hypertension.Oral labetalol in the management of stable angina pectoris in normotensive patients.From Bad to Worse: Paraganglioma Diagnosis during Induction of Labor for Coexisting Preeclampsia.The management of acute poisoning due to beta-adrenoceptor antagonists.The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.Clinical pharmacology of labetalol.Efficacy of intraoperative dexmedetomidine infusion on visualization of the surgical field in endoscopic sinus surgery.Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.Haemodynamic and metabolic effects of combined adrenergic alpha- and beta-receptor blockade with labetalol in the exercising human forearm.
P2860
Q28265575-672FACFA-918C-4D2A-8389-D368723FFE66Q34438864-AE85B213-AAFE-4CF1-8A6B-46A9FCF3DB10Q34518440-46252B4D-72D0-4E1C-A3FE-D4A21C233D2BQ36755157-A2B30C68-B8A1-4664-BFB1-432BE9E65B40Q37618226-7048FCB4-F8B3-4A70-AB82-082AE7F6263AQ38345394-AC0FA08B-9E17-44BF-A02C-AE2F0AAC3E3CQ38586764-51C569D5-CAC6-484E-A619-BB621C363753Q39296318-5258C505-85C5-464A-A7AF-C0CD35ADB341Q41760701-1F298B1B-35B3-4D83-AB95-AD86AE1BBF02Q41787088-3586C375-B131-45B9-A3A8-530A7A80C10DQ43201853-6AFEBF10-BE62-44F4-ACEC-D8679EF3A9D9Q43261907-2428BD23-6E11-4723-A160-8688DD610648Q54526850-C10786CA-FCD6-4A42-AFE4-0EB79EB59622Q54545344-080119A4-9585-4F06-87DA-DA1CB2BE0FCF
P2860
Pharmacological basis for antihypertensive effects of intravenous labetalol
description
1977 nî lūn-bûn
@nan
1977 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Pharmacological basis for antihypertensive effects of intravenous labetalol
@ast
Pharmacological basis for antihypertensive effects of intravenous labetalol
@en
Pharmacological basis for antihypertensive effects of intravenous labetalol
@nl
type
label
Pharmacological basis for antihypertensive effects of intravenous labetalol
@ast
Pharmacological basis for antihypertensive effects of intravenous labetalol
@en
Pharmacological basis for antihypertensive effects of intravenous labetalol
@nl
prefLabel
Pharmacological basis for antihypertensive effects of intravenous labetalol
@ast
Pharmacological basis for antihypertensive effects of intravenous labetalol
@en
Pharmacological basis for antihypertensive effects of intravenous labetalol
@nl
P2093
P2860
P356
P1476
Pharmacological basis for antihypertensive effects of intravenous labetalol
@en
P2093
A J Boakes
B N Prichard
D A Richards
E J Knight
P2860
P304
P356
10.1136/HRT.39.1.99
P407
P577
1977-01-01T00:00:00Z